These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 12190331)

  • 1. Mechanisms of clinically relevant drug interactions associated with tacrolimus.
    Christians U; Jacobsen W; Benet LZ; Lampen A
    Clin Pharmacokinet; 2002; 41(11):813-51. PubMed ID: 12190331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic considerations relating to tacrolimus dosing in the elderly.
    Staatz CE; Tett SE
    Drugs Aging; 2005; 22(7):541-57. PubMed ID: 16038570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
    Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
    Clin Pharmacokinet; 2004; 43(11):741-62. PubMed ID: 15301578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug interactions with tacrolimus.
    van Gelder T
    Drug Saf; 2002; 25(10):707-12. PubMed ID: 12167066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy in elderly transplant recipients: a guide to clinically significant drug interactions.
    Kuypers DR
    Drugs Aging; 2009; 26(9):715-37. PubMed ID: 19728747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation.
    Anglicheau D; Flamant M; Schlageter MH; Martinez F; Cassinat B; Beaune P; Legendre C; Thervet E
    Nephrol Dial Transplant; 2003 Nov; 18(11):2409-14. PubMed ID: 14551375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroid interactions with cyclosporine, tacrolimus, mycophenolate, and sirolimus: fact or fiction?
    Lam S; Partovi N; Ting LS; Ensom MH
    Ann Pharmacother; 2008 Jul; 42(7):1037-47. PubMed ID: 18594053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of rifampin on tacrolimus pharmacokinetics in healthy volunteers.
    Hebert MF; Fisher RM; Marsh CL; Dressler D; Bekersky I
    J Clin Pharmacol; 1999 Jan; 39(1):91-6. PubMed ID: 9987705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of everolimus.
    Kirchner GI; Meier-Wiedenbach I; Manns MP
    Clin Pharmacokinet; 2004; 43(2):83-95. PubMed ID: 14748618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.
    Lampen A; Christians U; Guengerich FP; Watkins PB; Kolars JC; Bader A; Gonschior AK; Dralle H; Hackbarth I; Sewing KF
    Drug Metab Dispos; 1995 Dec; 23(12):1315-24. PubMed ID: 8689938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of St. John's wort (Hypericum perforatum) on tacrolimus pharmacokinetics in healthy volunteers.
    Hebert MF; Park JM; Chen YL; Akhtar S; Larson AM
    J Clin Pharmacol; 2004 Jan; 44(1):89-94. PubMed ID: 14681346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretransplantation pharmacokinetic curves of tacrolimus in HIV-infected patients on ritonavir-containing cART: a pilot study.
    van Maarseveen EM; Crommelin HA; Mudrikova T; van den Broek MP; van Zuilen AD
    Transplantation; 2013 Jan; 95(2):397-402. PubMed ID: 23250333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the pharmacokinetics of tacrolimus and microemulsified cyclosporin in paediatric renal transplant recipients.
    Renton KW; Crocker JF; McLellan H; Acott PD
    Eur J Clin Pharmacol; 2004 Aug; 60(6):421-6. PubMed ID: 15232662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interaction between turmeric and tacrolimus possible].
    Lakartidningen; 2010 May 5-11; 107(18):1238. PubMed ID: 20521597
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.
    Williams D; Feely J
    Clin Pharmacokinet; 2002; 41(5):343-70. PubMed ID: 12036392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of tacrolimus in pediatric liver transplantation: early posttransplantation clearance.
    Wallin JE; Bergstrand M; Wilczek HE; Nydert PS; Karlsson MO; Staatz CE
    Ther Drug Monit; 2011 Dec; 33(6):663-72. PubMed ID: 22105583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients.
    Masuda S; Inui K
    Pharmacol Ther; 2006 Oct; 112(1):184-98. PubMed ID: 16759707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of tacrolimus in adult kidney transplant recipients.
    Staatz CE; Willis C; Taylor PJ; Tett SE
    Clin Pharmacol Ther; 2002 Dec; 72(6):660-9. PubMed ID: 12496747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical analysis of the interplay between cytochrome P450 3A and P-glycoprotein: recent insights from knockout and transgenic mice.
    van Waterschoot RA; Schinkel AH
    Pharmacol Rev; 2011 Jun; 63(2):390-410. PubMed ID: 21490128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ritonavir. Clinical pharmacokinetics and interactions with other anti-HIV agents.
    Hsu A; Granneman GR; Bertz RJ
    Clin Pharmacokinet; 1998 Oct; 35(4):275-91. PubMed ID: 9812178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.